Structures by: Tu G. G.
Total: 6
(2<i>R</i>)-<i>N</i>-[5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-yl]-2- (cinnamoylamino)propanamide
C20H17ClN4O2S
Acta Crystallographica Section E (2008) 64, 10 o2006
a=6.6324(15)Å b=8.575(2)Å c=34.367(8)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>)-2-Cinnamoylamino-<i>N</i>-[5-(4-methoxyphenyl) -1,3,4-thiadiazol-2-yl]propanamide
C21H20N4O3S
Acta Crystallographica Section E (2008) 64, 10 o1887
a=9.082(3)Å b=9.849(3)Å c=13.644(4)Å
α=79.587(4)° β=83.253(4)° γ=65.458(4)°
2-Benzoylamino-<i>N</i>-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]ethanamide
C17H13BrN4O2S
Acta Crystallographica Section E (2009) 65, 2 o325
a=4.020(4)Å b=13.706(9)Å c=16.210(5)Å
α=113.334(17)° β=94.018(19)° γ=92.78(2)°
4-Chloro-<i>N</i>-[3-methyl-1-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2- yl)butyl]benzamide
C14H16ClN3O2S
Acta Crystallographica Section E (2010) 66, 6 o1381
a=6.0171(6)Å b=15.3120(15)Å c=18.1493(17)Å
α=90.00° β=90.00° γ=90.00°
1-(3-Chlorobenzyloxy)urea
C8H9ClN2O2
Acta Crystallographica Section E (2009) 65, 12 o2983
a=10.8300(10)Å b=13.9410(14)Å c=14.2750(15)Å
α=69.6720(10)° β=75.828(2)° γ=70.3880(10)°
(2<i>R</i>,3<i>R</i>)-<i>N</i>-(4-Chlorophenyl)-2,3-dihydroxy-<i>N</i>'-(5- phenyl-1,3,4-thiadiazol-2-yl)succinamide
C18H15ClN4O4S
Acta Crystallographica Section E (2010) 66, 4 o765
a=41.381(3)Å b=5.1744(5)Å c=8.7442(9)Å
α=90.00° β=98.3150(10)° γ=90.00°